MedTrace Logo

A Brief Case Management Intervention for People Involuntarily Admitted to a Psychiatric Hospital

NCT06320457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2025-04-04

No results posted yet for this study

Summary

The goal of this clinical trial is to assess whether a brief case management intervention aimed at promoting personal recovery and reducing the negative effects of coercion among people involuntarily admitted to a psychiatric hospital would be well accepted by them, practically feasible and useful. The main questions it aims to answer are:

* Is the case management intervention acceptable and feasible?
* What are the preliminary effects of the case management intervention on patients' personal recovery and its sub-dimensions, as well as on their level of perceived coercion and their global satisfaction with hospital care?

Participants will be asked to take part in:

* the five sessions of the case management intervention;
* two evaluation sessions (pre and post-intervention);
* a final in-depth semi-structured interview (optional).

Conditions

  • Psychiatric Disorder
  • Involuntary Psychiatric Hospitalization

Interventions

OTHER

Brief case management intervention

The brief case management intervention aims to support patients during the difficult phase of involuntary hospitalisation and reduce the impact of this short-term event on their long-term recovery process. The intervention starts during the hospital stay, at the latest one week after admission, and lasts for a maximum of one month after discharge. The intervention consists of five sessions, the order of which may vary according to the specific needs of the patient: 1. Personal account of involuntary hospitalisation and its consequences 2. Presentation of the personal recovery model and the tools to promote it and prevent coercion 3. Introduction to the personal recovery plan 4. Network meeting and discussion on "dignity of risk" 5. Personal recovery plan

Sponsors & Collaborators

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • Charles Bonsack · Centre Hospitalier Universitaire Vaudois, CHUV

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-15
Primary Completion
2024-10-31
Completion
2025-01-21

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06320457 on ClinicalTrials.gov